These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 330748)

  • 1. BCG-induced murine effector cells. I. Cytolytic activity in peritoneal exudates: an early response to BCG.
    Tracey DE; Wolfe SA; Durdik JM; Henney CS
    J Immunol; 1977 Sep; 119(3):1145-51. PubMed ID: 330748
    [No Abstract]   [Full Text] [Related]  

  • 2. BCG-induced murine effector cells. II. Characterization of natural killer cells in peritoneal exudates.
    Wolfe SA; Tracey DE; Henney CS
    J Immunol; 1977 Sep; 119(3):1152-8. PubMed ID: 330750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular mechanisms of genetically controlled host resistance to Mycobacterium bovis (BCG).
    Gros P; Skamene E; Forget A
    J Immunol; 1983 Oct; 131(4):1966-72. PubMed ID: 6311901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic control of natural resistance to Mycobacterium bovis (BCG) in mice.
    Gros P; Skamene E; Forget A
    J Immunol; 1981 Dec; 127(6):2417-21. PubMed ID: 6795274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The requirement for macrophages in the augmentation of natural killer cell activity by BCG.
    Tracey DE
    J Immunol; 1979 Aug; 123(2):840-5. PubMed ID: 222845
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of in vitro cytotoxic responses by BCG-induced macrophage-like suppressor cells. II. Suppression occurs at the level of a "helper" T cell.
    Klimpel GR; Okada M; Henney CS
    J Immunol; 1979 Jul; 123(1):350-7. PubMed ID: 156233
    [No Abstract]   [Full Text] [Related]  

  • 7. Specific and nonspecific antitumor immunity. II. Macrophage-mediated nonspecific effector activity induced by BCG and similar agents.
    Germain RN; Williams RM; Benacerraf B
    J Natl Cancer Inst; 1975 Mar; 54(3):709-20. PubMed ID: 1091741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural cytotoxic cells against solid tumors in mice. I. Strain and age distribution and target cell susceptibility.
    Stutman O; Paige CJ; Figarella EF
    J Immunol; 1978 Nov; 121(5):1819-26. PubMed ID: 712067
    [No Abstract]   [Full Text] [Related]  

  • 9. Genetic differences in BCG-induced resistance to Schistosoma mansoni are not controlled by genes within the major histocompatibility complex of the mouse.
    Civil RH; Mahmoud AA
    J Immunol; 1978 Mar; 120(3):1070-2. PubMed ID: 344795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage function in tumor-bearing mice: tumoricidal and chemotactic responses of macrophages activated by infection with Mycobacterium bovis, strain BCG.
    Meltzer MS; Stevenson MM
    J Immunol; 1977 Jun; 118(6):2176-81. PubMed ID: 325142
    [No Abstract]   [Full Text] [Related]  

  • 11. Macrophage activation for tumor cytotoxicity: genetic variation in macrophage tumoricidal capacity among mouse strains.
    Boraschi D; Meltzer MS
    Cell Immunol; 1979 Jun; 45(1):188-94. PubMed ID: 378423
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum from LPS nonresponder C3H/HeJ mice does not support the formation of functional EAC reagents.
    Hoffmann MK
    J Immunol; 1978 Aug; 121(2):619-21. PubMed ID: 355548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cytotoxic effect of BCG-activated macrophages on tumor target cells in vitro].
    Viadro MM
    Biull Eksp Biol Med; 1979 Jan; 87(1):36-9. PubMed ID: 760842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variation among mouse strains in responsiveness to migration inhibitory factor.
    Tagliabue A; Herberman RB; McCoy JL
    Cell Immunol; 1979 Jul; 45(2):464-8. PubMed ID: 380823
    [No Abstract]   [Full Text] [Related]  

  • 15. Reversal by peritoneal adherent cells of tumor cell suppression of T cell-mediated immunity.
    Ting CC; Rodrigues D
    J Immunol; 1979 Aug; 123(2):801-7. PubMed ID: 156764
    [No Abstract]   [Full Text] [Related]  

  • 16. Natural cytotoxic cells against solid tumors in mice. II. Some characteristics of the effector cells.
    Paige CJ; Figarella EF; Cuttito MJ; Cahan A; Stutman O
    J Immunol; 1978 Nov; 121(5):1827-35. PubMed ID: 361891
    [No Abstract]   [Full Text] [Related]  

  • 17. Macrophage activation for tumor cytotoxicity: induction of tumoricidal macrophages by supernatants of PPD-stimulated Bacillus Calmette-Guérin-immune spleen cell cultures.
    Ruco LP; Meltzer MS
    J Immunol; 1977 Sep; 119(3):889-96. PubMed ID: 330759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological intervention in neoplasia.
    Weiss DW
    Johns Hopkins Med J Suppl; 1974; 3():131-56. PubMed ID: 4371312
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of macrophages in tumour immunity. I. Co-operation between macrophages and lymphoid cells in syngeneic tumour immunity.
    Evans R; Alexander P
    Immunology; 1972 Oct; 23(4):615-26. PubMed ID: 5084104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin synthesis inhibitors potentiate the BCG-induced augmentation of natural killer cell activity.
    Tracey DE; Adkinson NF
    J Immunol; 1980 Jul; 125(1):136-41. PubMed ID: 6991599
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.